Literature DB >> 23247043

Biosocial processes predicting multisystemic therapy treatment response.

Stacy R Ryan1, Patricia A Brennan, Phillippe B Cunningham, Sharon L Foster, Rebecca L Brock, Elizabeth Whitmore.   

Abstract

This study examined biological (testosterone) and social (deviant peer affiliation) factors early in treatment as predictors of treatment outcome among adolescent boys receiving Multisystemic Therapy (MST) in community settings. Outcome variables included changes in youth aggression and delinquency as reported by the primary caregiver. Testosterone and deviant peer affiliation were assessed at treatment onset; and outcome variables (aggression and delinquency) were assessed at treatment onset, mid-treatment and end-of-treatment. Participants were 112 adolescent boys (M age=15.42, SD=1.31) and their caregivers. Growth curve analyses revealed that the combination of high testosterone and high deviant peer affiliation early in treatment were significantly associated with less of a decline in aggression and delinquency over the course of treatment. Results provide novel evidence for the role of testosterone in the prediction of future externalizing behaviors. Clinical and theoretical implications are discussed.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23247043      PMCID: PMC3882153          DOI: 10.1016/j.biopsycho.2012.12.002

Source DB:  PubMed          Journal:  Biol Psychol        ISSN: 0301-0511            Impact factor:   3.251


  26 in total

Review 1.  The "trouble" with salivary testosterone.

Authors:  Douglas A Granger; Elizabeth A Shirtcliff; Alan Booth; Katie T Kivlighan; Eve B Schwartz
Journal:  Psychoneuroendocrinology       Date:  2004-11       Impact factor: 4.905

Review 2.  Evidence-based psychosocial treatments for adolescent substance abuse.

Authors:  Holly Barrett Waldron; Charles W Turner
Journal:  J Clin Child Adolesc Psychol       Date:  2008-01

3.  Multisystemic treatment of serious juvenile offenders: long-term prevention of criminality and violence.

Authors:  C M Borduin; B J Mann; L T Cone; S W Henggeler; B R Fucci; D M Blaske; R A Williams
Journal:  J Consult Clin Psychol       Date:  1995-08

Review 4.  Testosterone and dominance in men.

Authors:  A Mazur; A Booth
Journal:  Behav Brain Sci       Date:  1998-06       Impact factor: 12.579

Review 5.  The testosterone-cortisol ratio: A hormonal marker for proneness to social aggression.

Authors:  David Terburg; Barak Morgan; Jack van Honk
Journal:  Int J Law Psychiatry       Date:  2009-05-15

Review 6.  Testosterone and human aggression: an evaluation of the challenge hypothesis.

Authors:  John Archer
Journal:  Neurosci Biobehav Rev       Date:  2005-02-25       Impact factor: 8.989

7.  Association of testosterone and dihydrotestosterone with externalizing behavior in adolescent boys and girls.

Authors:  Athanasios Maras; Manfred Laucht; Dirk Gerdes; Cindy Wilhelm; Sabina Lewicka; Doris Haack; Lucie Malisova; Martin H Schmidt
Journal:  Psychoneuroendocrinology       Date:  2003-10       Impact factor: 4.905

8.  Testosterone and child and adolescent adjustment: the moderating role of parent-child relationships.

Authors:  Alan Booth; David R Johnson; Douglas A Granger; Ann C Crouter; Susan McHale
Journal:  Dev Psychol       Date:  2003-01

9.  Testosterone, antisocial behavior, and social dominance in boys: pubertal development and biosocial interaction.

Authors:  Richard Rowe; Barbara Maughan; Carol M Worthman; E Jane Costello; Adrian Angold
Journal:  Biol Psychiatry       Date:  2004-03-01       Impact factor: 13.382

10.  A self-report measure of pubertal status: Reliability, validity, and initial norms.

Authors:  A C Petersen; L Crockett; M Richards; A Boxer
Journal:  J Youth Adolesc       Date:  1988-04
View more
  1 in total

1.  Social Interface Model: Theorizing Ecological Post-Delivery Processes for Intervention Effects.

Authors:  Jonathan Pettigrew; Jeremy Segrott; Colter D Ray; Hannah Littlecott
Journal:  Prev Sci       Date:  2018-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.